Rondón CJ, Rondón AR, Fajardo RM, Morales VCL, Rondón CRY

Language: Spanish
References: 14
Page: 1-10
PDF size: 443.09 Kb.

ABSTRACT

Introduction: Leprosy is one of the diseases first described in the ancient world. It is a chronic, bacterial, granulomatous disease of infectious etiology, caused by Mycobacterium leprae.
Objective: To characterize leprosy clinical-epidemiologically.
Methods: An observational, retrospective, descriptive and cross-sectional study was carried out in Guisa Municipality, Granma Province. The study universe was made up of the total number of patients diagnosed with leprosy in the period from January 2015 to December 2020 (N=9). The statistical method of percentage calculation was applied.
Results: The highest incidence was observed in 2016, with five cases (55.6 %). The highest representation corresponded to the male sex, with six cases (66.7 %); and the age group 45-59 years, with five cases (55.6 %). The lepromatous clinical form (Madrid classification) had the highest incidence, with five cases (55.6 %); while, according to the operational or sanitary classification, the multibacillary form had the highest representation.
Conclusions: Leprosy is not currently a health concern in Guisa Municipality. Active screening and timely diagnosis of this disease can reduce the appearance of its complications and the disability that it causes.

REFERENCES

1. Goderich R. Temas de Medicina Interna. 5 ed. La Habana: Editorial Ciencias Médicas; 2017. p. 605-12.

2. Estrategia mundial para la lepra 2016–2020. Acelerar la acción hacia un mundo sin lepra. Guía de monitoreo y evaluación. Organización Mundial de la Salud. 2017 [acceso 29/12/2020]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/254907/9789290225874sp.pdf;jsessinid=F9F30C31F012767DBFE5FE5F2A82D8DD?sequence=11

3. Ministério da Saúde (BR). Saúde Brasil 2017: uma análise da situação de saúde e os desafios para o alcance dos objetivos de desenvolvimento sustentável. Brasília (DF): Ministério da Saúde; 2018. [acceso 29/12/2020]. Disponible en: http://bvsms.saude.gov.br/bvs/publicacoes/saude_brasil_2017.pdf

4. Tablada Robinet ME, Marrero Rodríguez H, López Pupo N, Mulén Tablada D, Pérez González O. Aspectos clínicos y epidemiológicos en pacientes timorenses con enfermedad de Hansen. MEDISAN. 2019 [acceso 29/12/2020];23(1):89-99. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192019000100089&lng=esCuba

5. Dirección de registros médicos y estadísticas de salud. Anuario estadístico de salud, 2019. La Habana: Ministerio de Salud Pública; 2020. p.71-3. [acceso 29/12/2020]. Disponible en: http://files.sld.cu/bvscuba/files/2020/04/Anuario-Electrónico-Español-2018-ed-2019.pdf

6. World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). Regional Office for South-New Delhi: WHO; 2016. [acceso 29/12/2020]. Disponible en: http://apps.searo.who.int/PDS_DOCS/B0330.pdf

7. Romero Cantillo R, Durán Rodríguez R, Rubio Méndez A. Comportamiento de la enfermedad de Hansen en municipio Baracoa, Guantánamo. Rev Inf Cient. 2016 [acceso 29/12/2020];95(5):702-10. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/58/2154

8. Méndez Pérez S, Hinojosa Machado K, Gonzáles Arguelles Y. Presentaciones de leproreacción en pacientes asilados. Rev Inf Cient. 2015 [acceso 29/12/2020];94(6):1294-305. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/158/1202

9. Quevedo Lorenzo I, Yánez Crombet A, Delgado Gutiérrez OL, Dominguez Núñez CR, Bejar Viltres HL. Algunos aspectos clínicos-epidemiológicos de la enfermedad de Hansen en el municipio Yara. Granma. 2013-2017. Revista Multimed. 2019 [acceso 29/12/2020];23(1):[aprox. 10 p.]. Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/1095

10. Rojas-Caraballo N, Álvarez-Borjas J, Lagos-Ordoñez Kathy J, Aroche-Domínguez M E, Laffita-Núñez M. Caracterización de la lepra en el municipio de Guantánamo en el período 2015-2019. Rev. Inf. Cient. 2020 [acceso 29/12/2020];99(5):435-41. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-99332020000500435&lng=es

11. Valiente Hernández Y, Hernández Moya M. Costos directos e indirectos del diagnóstico y tratamiento de pacientes con lepra. MEDISAN. 2016 [acceso 29/12/2020];20(3):299-305. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102930192016000300004&lng=es

12. World Health Organization, Regional Office for South-East Asia, Global Leprosy Programmer. Global Leprosy Strategy 2016-2020: Operational Manual 2016. Accelerating towards a leprosy-free world. New Delhi: WHO Regional Office for South-East Asia; 2016 [acceso 29/12/2020]. Disponible en: http://apps.searo.who.int/PDS_DOCS/B5233.pdf

13. World Health Organization, Regional Office for South-East Asia, Global Leprosy Programmer. Global Leprosy Strategy 2016–2020: Monitoring and Evaluation Guide. Accelerating towards a leprosy-free world. New Delhi: WHO Regional Office for South-East Asia; 2017 [acceso 29/12/2020]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/254907/9789290225492-eng.pdf

14. World Health Organization. WHO Handbook for Guideline Development. 2nd ed. Geneva: WHO; 2019 [acceso 29/12/2020]. Disponible en: http://www.who.int/publications/guidelines/handbook_2nd_ed.pdf